/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

The US imposes new rules requiring that CHIPS Act beneficiaries agree not to expand manufacturing capacity in “countries of concern”, like China, for 10 years

Commerce department imposes new rules on beneficiaries of $39bn programme  —  Chipmakers must agree not to expand capacity …

Financial Times Demetri Sevastopulo

Context & Ripple Effects

This rule is the operational teeth for the Chips and Science Act's funding bar passed the previous August, which already blocked subsidized companies from adding advanced-chip production in China but left the terms vague. Commerce is now converting that statutory prohibition into a signed agreement every beneficiary must accept before seeing any of the $39bn.

The arc runs fast from here: within weeks Commerce proposes hard numeric caps — 5% growth for advanced chips, 10% for legacy — and by September it finalizes the framework in rules locking the ten-year expansion limits. The measure matters because Intel, TSMC, Samsung and others are all positioned to take subsidy money while running large China operations.

First-order effects

  • Every chipmaker applying for CHIPS Act funds must sign a ten-year covenant not to expand capacity in China or other countries of concern, making the pledge a condition of disbursement rather than a policy preference.
  • Intel, TSMC, and other beneficiaries with existing Chinese fabs face a direct trade-off between US subsidies and future capacity flexibility inside China.

Second-order effects

  • China responds by hardening its own industrial base: sources report a rule requiring domestic chipmakers to use at least 50% locally made equipment when adding new capacity, accelerating substitution away from foreign toolmakers like ASML.
  • Companies weighing US money versus China market access split their roadmaps geographically — legacy-node expansion migrates to non-subsidized players willing to keep building in China, reshaping who serves that demand.

Third-order effects

  • Subsidy conditions become a structural feature of semiconductor competition: capital grants now double as geopolitical alignment contracts, and the September finalization shows Washington iterating from broad bans toward quantified caps.
  • If the pattern holds, decoupling deepens by attrition — each funding round narrows where advanced capacity can physically be built, pushing China toward self-sufficiency drives like the ASML DUV retrofitting efforts reported in the related coverage.

The trend: Industrial policy is fusing with export control: US chip subsidies increasingly function as instruments for capping China's fab buildout, and Beijing answers with forced localization rather than retreat.

Discussion

  • @steve_hanke Steve Hanke on x
    The US Dept. of Commerce is imposing a new rule targeting China: chipmakers that receive federal funds must agree not to expand capacity in “foreign countries of concern” for the next 10 yrs. INDUSTRIAL POLICY ON STEROIDS. https://www.ft.com/...
  • @dimi Demetri on x
    US chipmakers receiving federal funds barred from expanding in China for 10 years and must agree not to do stock buybacks https://www.ft.com/...
  • @srinathraghava3 Srinath Raghavan on x
    Chipmakers must agree not to expand capacity in China for a decade...must also not “knowingly engage in any joint research or technology licensing effort with a foreign entity of concern that involves sensitive technologies or products”. https://www.ft.com/...